ARCHIVES

DCBD Board Okays Recombinant DNA Diagnosis Concept, Two Others, But Rejects Three

This article is from The Cancer Letter archive.

Vol. 09 No. 22 | June 3, 1983

Download PDF Visit The Full Archive

Related Articles

With A Flat Budget, Niederhuber Outlines NCI Priorities In Speech To ASCO Meeting.

June 13, 2008

NCI-Approved Group, Center Clinical Trials Listed

May 25, 2007

Cephalon To Plead Guilty, Pay $425M For Off-Label Marketing.

October 3, 2008

Blood Donors With Undertrain HTLV-3 Should Be Notified, Consensus Panel Says

July 18, 1986

No Benefit To Kidney Removal For Elderly With Kidney Cancer

May 28, 2010

Hematologic Malignancies: ASCO Meeting Highlights New Approaches To Treatment

July 30, 2004